Home/Filings/4/0001677141-26-000001
4//SEC Filing

Kapadia Sandip 4

Accession 0001677141-26-000001

CIK 0001802665other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 8:39 PM ET

Size

5.3 KB

Accession

0001677141-26-000001

Insider Transaction Report

Form 4
Period: 2026-01-15
Kapadia Sandip
CHIEF FINANCIAL OFFICER
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-01-15$35.92/sh20,961$752,8330 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Christian Ulrich, Attorney-in-Fact|2026-01-20

Issuer

Harmony Biosciences Holdings, Inc.

CIK 0001802665

Entity typeother

Related Parties

1
  • filerCIK 0001677141

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 8:39 PM ET
Size
5.3 KB